Blood Group Typing Market to Reach $5.5 Billion by 2031, Driven by Rising Demand for Transfusions and Prenatal Testing
-
The global blood group typing market is projected to reach USD 5.5 billion by 2031, with a CAGR of 8.8% from 2022-2031. The market was valued at USD 2.6 billion in 2022.
-
Key drivers include the increasing number of road accidents requiring blood transfusions and the growing demand from forensic sciences and prenatal testing.
-
North America leads the market currently due to the high number of road accidents in the U.S. Europe is another major market.
-
Recent mergers and acquisitions between companies like Grifols, Biotest AG, Werfer, and Immucor Inc. are introducing innovations in the market.
-
Key players operating in the global blood group typing market include Grifols S.A., Bio-Rad Laboratories Inc., Merck KGaA, Ortho Clinical Diagnostics, and AliveDx ABG Health Care GmbH among others.